Document is current
Any future updates will be listed below
-
Authors
Ziaeian, Boback http://orcid.org/0000-0001-9787-3649
Xu, Haolin
Matsouaka, Roland A.
Xian, Ying
Khan, Yosef
Schwamm, Lee S.
Smith, Eric E.
Fonarow, Gregg C.
-
Funding
Funding for this research was provided by:
American Heart Association (17SDG33630113)
National Center for Advancing Translational Sciences (KL2TR001882)
-
License Information
Text and Data Mining valid from 2021-02-04
Version of Record valid from 2021-02-04
-
More Information
Article History
Received: 2 November 2020
Accepted: 22 January 2021
First Online: 4 February 2021
Ethics approval and consent to participate
: A waiver for consent is applied to this study and the Get With The Guideline Registry Program through the Duke University IRB.
: Not applicable.
: Boback Ziaeian: none.Gregg C. Fonarow: Research: NIH; Consulting: Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis.Lee H Schwamm: Research grants: NINDS, NIA, PCORI; Serves on scientific advisory boards for (1) LifeImage (2) Medtronic clinical trial design for AF related stroke ExternalRef removed (3) Penumbra MIND study DSMB ExternalRef removed, (4) Genentech TIMELESS study ExternalRef removed Steering Committee, and expert advisory panel on late window thrombolysis, (5) Diffusion Pharma DSMB PHAST-TSC NCT03763929. Serves as volunteer chair of the AHA/ASA stroke systems of care advisory committee, and ASA Advisory Committee of the AHA Board of Directors [unpaid].
